# The ASPIRE Trial: AchilleS tendinoPathy Treated With cortIcosteRoid injEctions

> **NCT07650396** · PHASE3 · RECRUITING · sponsor: **Erasmus Medical Center** · enrollment: 276 (estimated)

## Conditions studied

- Achilles Tendinopathy (AT)

## Interventions

- **OTHER:** Standard care
- **DRUG:** Depo-Medrol (methylprednisolone acetate 40 mg) combined with lidocaine
- **DRUG:** placebo injections consisting of lidocaine only

## Key facts

- **NCT ID:** NCT07650396
- **Lead sponsor:** Erasmus Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-03
- **Primary completion:** 2027-12-31
- **Final completion:** 2028-10-31
- **Target enrollment:** 276 (ESTIMATED)
- **Last updated:** 2026-06-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07650396

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07650396, "The ASPIRE Trial: AchilleS tendinoPathy Treated With cortIcosteRoid injEctions". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07650396. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*